Streptococcal inhibitor of complement-mediated lysis (SIC): An anti-inflammatory virulence determinant

Microbiology

Volumn 156, Issue 12, 2010, Pages 3660-3668

  Åkesson, Per ^a   Herwald, Heiko ^a   Rasmussen, Magnus ^a   Håkansson, Katarina ^a   Abrahamson, Magnus ^a   Hasan, Ahmed A K ^b,e   Schmaier, Alvin H ^c   Müller Esterl, Werner ^d   Björck, Lars ^a  

^a LUND UNIVERSITY   (Sweden)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d GOETHE UNIVERSITY   (Germany)

^e NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; BRADYKININ; CYSTATIN C; HIGH MOLECULAR WEIGHT KININOGEN; LOW MOLECULAR WEIGHT KININOGEN; STREPTOCOCCAL INHIBITOR OF COMPLEMENT MEDIATED LYSIS; UNCLASSIFIED DRUG;

ARTICLE; BACTERIAL VIRULENCE; BINDING SITE; BLOOD CLOTTING; CELL STRUCTURE; CONTROLLED STUDY; ENDOTHELIUM CELL; HEMOLYSIS; HOST RESISTANCE; HUMAN; HUMAN CELL; MOLECULAR INTERACTION; NONHUMAN; PATHOGENICITY; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN IMMOBILIZATION; STREPTOCOCCUS PYOGENES;

BACTERIAL PROTEINS; COMPLEMENT SYSTEM PROTEINS; CYSTATIN C; HOST-PATHOGEN INTERACTIONS; HUMANS; KININOGEN, HIGH-MOLECULAR-WEIGHT; PROTEIN BINDING; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS PYOGENES; VIRULENCE;

STREPTOCOCCUS PYOGENES;

EID: 78650039436     PISSN: 13500872     EISSN: None     Source Type: Journal    
DOI: 10.1099/mic.0.039578-0     Document Type: Article

References (53)

1. Abrahamson, M. (1994). Cystatins. Methods Enzymol 244, 685-700.
2. Abrahamson, M., Barrett, A. J., Salvesen, G. & Grubb, A. (1986). Isolation of six cysteine proteinase inhibitors from human urine. Their physicochemical and enzyme kinetic properties and concentrations in biological fluids. J Biol Chem 261, 11282-11289.
3. Abrahamson, M., Dalboge, H., Olafsson, I., Carlsen, S. & Grubb, A. (1988). Efficient production of native, biologically active human cystatin C by Escherichia coli. FEBS Lett 236, 14-18.
4. Åkesson, P., Cooney, J., Kishimoto, F. & Björck, L. (1990). Protein H - a novel IgG binding bacterial protein. Mol Immunol 27, 523-531.
5. Åkesson, P., Schmidt, K. H., Cooney, J. & Björck, L. (1994). M1 protein and protein H: IgGFc- and albumin-binding streptococcal surface proteins encoded by adjacent genes. Biochem J 300, 877-886.
6. Åkesson, P., Sjöholm, A. G. & Björck, L. (1996). Protein SIC, a novel extracellular protein of Streptococcus pyogenes interfering with complement function. J Biol Chem 271, 1081-1088.
7. Auerswald, E. A., Rossler, D., Mentele, R. & Assfalg-Machleidt, I. (1993). Cloning, expression and characterization of human kininogen domain 3. FEBS Lett 321, 93-97. (Pubitemid 23112098)
8. Ben Nasr, A., Olsén, A., Sjöbring, U., Müller-Esterl, W. & Björck, L. (1996). Assembly of human contact phase proteins and release of bradykinin at the surface of curli-expressing Escherichia coli. Mol Microbiol 20, 927-935.
9. Ben Nasr, A., Herwald, H., Sjöbring, U., Renne, T., Müller-Esterl, W. & Björck, L. (1997). Absorption of kininogen from human plasma by Streptococcus pyogenes is followed by the release of bradykinin. Biochem J 326, 657-660.
10. Berge, A. & Björck, L. (1995). Streptococcal cysteine proteinase releases biologically active fragments of streptococcal surface proteins. J Biol Chem 270, 9862-9867.
11. Bhoola, K. D., Figueroa, C. D. & Worthy, K. (1992). Bioregulation of kinins: kallikreins, kininogens, and kininases. Pharmacol Rev 44, 1-80.
12. Binks, M. J., Fernie-King, B. A., Seilly, D. J., Lachmann, P. J. & Sriprakash, K. S. (2005). Attribution of the various inhibitory actions of the streptococcal inhibitor of complement (SIC) to regions within the molecule. J Biol Chem 280, 20120-20125.
13. Colman, R. W. & Schmaier, A. H. (1997). Contact system: a vascular biology modulator with anticoagulant, profibrinolytic, antiadhesive, and proinflammatory attributes. Blood 90, 3819-3843.
14. Colman, R. W., Pixley, R. A., Najamunnisa, S., Yan, W., Wang, J., Mazar, A. & McCrae, K. R. (1997). Binding of high molecular weight kininogen to human endothelial cells is mediated via a site within domains 2 and 3 of the urokinase receptor. J Clin Invest 100, 1481-1487.
15. Curtis, N. (1996). Invasive group A streptococcal infection. Curr Opin Infect Dis 9, 191-202.
16. de Château, M. & Björck, L. (1994). Protein PAB, a mosaic albumin-binding bacterial protein representing the first contemporary example of module shuffling. J Biol Chem 269, 12147-12151.
17. DeLa Cadena, R. A. & Colman, R. W. (1992). The sequence HGLGHGHEQQHGLGHGH in the light chain of high molecular weight kininogen serves as a primary structural feature for zinc-dependent binding to an anionic surface. Protein Sci 1, 151-160.
18. Egesten, A., Eliasson, M., Johansson, H. M., Olin, A. I., Mörgelin, M., Mueller, A., Pease, J. E., Frick, I. M. & Björck, L. (2007). The CXC chemokine MIG/CXCL9 is important in innate immunity against Streptococcus pyogenes. J Infect Dis 195, 684-693. (Pubitemid 46273042)
19. Facklam, R. F., Martin, D. R., Lovgren, M., Johnson, D. R., Efstratiou, A., Thompson, T. A., Gowan, S., Kriz, P., Tyrrell, G. J. & other authors (2002). Extension of the Lancefield classification for group A streptococci by addition of 22 new M protein gene sequence types from clinical isolates: emm103 to emm124. Clin Infect Dis 34, 28-38.
20. Fernie-King, B. A., Seilly, D. J., Davies, A. & Lachmann, P. J. (2002). Streptococcal inhibitor of complement inhibits two additional components of the mucosal innate immune system: secretory leukocyte proteinase inhibitor and lysozyme. Infect Immun 70, 4908-4916.
21. Fischetti, V. A. (1989). Streptococcal M protein: molecular design and biological behavior. Clin Microbiol Rev 2, 285-314.
22. Frick, I. M., Åkesson, P., Rasmussen, M., Schmidtchen, A. & Björck, L. (2003). SIC, a secreted protein of Streptococcus pyogenes that inactivates antibacterial peptides. J Biol Chem 278, 16561-16566.
23. Frick, I. M., Åkesson, P., Herwald, H., Mörgelin, M., Malmsten, M., Nägler, D. K. & Björck, L. (2006). The contact system - a novel branch of innate immunity generating antibacterial peptides. EMBO J 25, 5569-5578.
24. Grubb, A. (1992). Diagnostic value of analysis of cystatin C and protein HC in biological fluids. Clin Nephrol 38 (Suppl. 1), S20-S27.
25. Hartas, J. & Sriprakash, K. S. (1999). Streptococcus pyogenes strains containing emm12 and emm55 possess a novel gene coding for distantly related SIC protein. Microb Pathog 26, 25-33.
26. Hasan, A. A., Cines, D. B., Herwald, H., Schmaier, A. H. & Müller-Esterl, W. (1995). Mapping the cell binding site on high molecular weight kininogen domain 5. J Biol Chem 270, 19256-19261.
27. Hasan, A. A., Zisman, T. & Schmaier, A. H. (1998). Identification of cytokeratin 1 as a binding protein and presentation receptor for kininogens on endothelial cells. Proc Natl Acad Sci U S A 95, 3615-3620.
28. Herwald, H., Hasan, A. A., Godovac-Zimmermann, J., Schmaier, A. H. & Müller-Esterl, W. (1995). Identification of an endothelial cell binding site on kininogen domain D3. J Biol Chem 270, 14634-14642.
29. Herwald, H., Collin, M., Müller-Esterl, W. & Björck, L. (1996a). Streptococcal cysteine proteinase releases kinins: a virulence mechanism. J Exp Med 184, 665-673.
30. Herwald, H., Dedio, J., Kellner, R., Loos, M. & Müller-Esterl, W. (1996b). Isolation and characterization of the kininogen-binding protein p33 from endothelial cells. Identity with the gC1q receptor. J Biol Chem 271, 13040-13047.
31. Herwald, H., Mörgelin, M., Olsén, A., Rhen, M., Dahlbäck, B., Müller-Esterl, W. & Björck, L. (1998). Activation of the contact-phase system on bacterial surfaces - a clue to serious complications in infectious diseases. Nat Med 4, 298-302.
32. Herwald, H., Mörgelin, M., Svensson, H. G. & Sjöbring, U. (2001). Zinc-dependent conformational changes in domain D5 of high molecular mass kininogen modulate contact activation. Eur J Biochem 268, 396-404.
33. Hoe,N.P., Nakashima,K., Lukomski,S.,Grigsby, D., Liu,M., Kordari, P., Dou, S. J., Pan, X., Vuopio-Varkila, J. & other authors (1999). Rapid selection of complement-inhibiting protein variants in group A Streptococcus epidemic waves. Nat Med 5, 924-929.
34. Kapur, V., Majesky, M. W., Li, L. L., Black, R. A. & Musser, J. M. (1993a). Cleavage of interleukin 1 beta (IL-1 beta) precursor to produce active IL-1 beta by a conserved extracellular cysteine protease from Streptococcus pyogenes. Proc Natl Acad Sci U S A 90, 7676-7680.
35. Kapur, V., Topouzis, S., Majesky, M. W., Li, L. L., Hamrick, M. R., Hamill, R. J., Patti, J. M. & Musser, J. M. (1993b). A conserved Streptococcus pyogenes extracellular cysteine protease cleaves human fibronectin and degrades vitronectin. Microb Pathog 15, 327-346.
36. Koide, T. & Odani, S. (1987). Histidine-rich glycoprotein is evolutionarily related to the cystatin superfamily. Presence of two cystatin domains in the N-terminal region. FEBS Lett 216, 17-21.
37. Lukomski, S., Hoe, N. P., Abdi, I., Rurangirwa, J., Kordari, P., Liu, M., Dou, S. J., Adams, G. G. & Musser, J. M. (2000). Nonpolar inactivation of the hypervariable streptococcal inhibitor of complement gene (sic) in serotype M1 Streptococcus pyogenes significantly decreases mouse mucosal colonization. Infect Immun 68, 535-542.
38. Mangold, M., Siller, M., Roppenser, B., Vlaminckx, B. J., Penfound, T. A., Klein, R., Novak, R., Novick, R. P. & Charpentier, E. (2004). Synthesis of group A streptococcal virulence factors is controlled by a regulatory RNA molecule. Mol Microbiol 53, 1515-1527.
39. Martin, D. R. & Single, L. A. (1993). Molecular epidemiology of group A streptococcus M type 1 infections. J Infect Dis 167, 1112-1117.
40. Mason, J. W., Kleeberg, U., Dolan, P. & Colman, R. W. (1970). Plasma kallikrein and Hageman factor in Gram-negative bacteremia. Ann Intern Med 73, 545-551.
41. Mattsson, E., Herwald, H., Cramer, H., Persson, K., Sjöbring, U. & Björck, L. (2001). Staphylococcus aureus induces release of bradykinin in human plasma. Infect Immun 69, 3877-3882.
42. Müller-Esterl, W., Johnson, D. A., Salvesen, G. & Barrett, A. J. (1988). Human kininogens. Methods Enzymol 163, 240-256.
43. Musser, J. M. & Krause, R. M. (1998). The revival of group A streptococcal diseases with a commentary on staphylococcal toxic shock syndrome. In Emerging Infections, pp. 185-218. Edited by R. M. Krause & A. Fauci. San Diego: Academic Press.
44. Musser, J. M., Kapur, V., Kanjilal, S., Shah, U., Musher, D. M., Barg, N. L., Johnston, K. H., Schlievert, P. M., Henrichsen, J. & other authors (1993). Geographic and temporal distribution and molecular characterization of two highly pathogenic clones of Streptococcus pyogenes expressing allelic variants of pyrogenic exotoxin A (Scarlet fever toxin). J Infect Dis 167, 337-346.
45. Oehmcke, S., Shannon, O., von Köckritz-Blickwede, M., Mörgelin, M., Linder, A., Olin, A. I., Björck, L. & Herwald, H. (2009). Treatment of invasive streptococcal infection with a peptide derived from human high-molecular weight kininogen. Blood 114, 444-451.
46. Persson, K., Mörgelin, M., Lindbom, L., Alm, P., Björck, L. & Herwald, H. (2000). Severe lung lesions caused by Salmonella are prevented by inhibition of the contact system. J Exp Med 192, 1415-1424.
47. Pixley, R. A., Zellis, S., Bankes, P., DeLa Cadena, R. A., Page, J. D., Scott, C. F., Kappelmayer, J., Wyshock, E. G., Kelly, J. J. & Colman, R. W. (1995). Prognostic value of assessing contact system activation and factor V in systemic inflammatory response syndrome. Crit Care Med 23, 41-51.
48. Schmaier, A. H. & Colman, R. W. (1989). Platelet high-molecular- weight kininogen. Methods Enzymol 169, 276-296.
49. Stockbauer, K. E., Grigsby, D., Pan, X., Fu, Y. X., Mejia, L. M., Cravioto, A. & Musser, J. M. (1998). Hypervariability generated by natural selection in an extracellular complement-inhibiting protein of serotype M1 strains of group A Streptococcus. Proc Natl Acad Sci U S A 95, 3128-3133.
50. Tait, J. F. & Fujikawa, K. (1987). Primary structure requirements for the binding of human high molecular weight kininogen to plasma prekallikrein and factor XI. J Biol Chem 262, 11651-11656.
51. van Deuren, M., Brandtzaeg, P. & van der Meer, J. W. (2000). Update on meningococcal disease with emphasis on pathogenesis and clinical management. Clin Microbiol Rev 13, 144-166.
52. Wachtfogel, Y. T., DeLa Cadena, R. A., Kunapuli, S. P., Rick, L., Miller,M., Schultze, R. L., Altieri, D. C., Edgington, T. S. & Colman, R. W. (1994). High molecular weight kininogen binds to Mac-1 on neutrophils by its heavy chain (domain 3) and its light chain (domain 5). J Biol Chem 269, 19307-19312.
53. Wuillemin, W. A., Fijnvandraat, K., Derkx, B. H., Peters, M., Vreede, W., ten Cate, H. & Hack, C. E. (1995). Activation of the intrinsic pathway of coagulation in children with meningococcal septic shock. Thromb Haemost 74, 1436-1441.